These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17686472)
1. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse. Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472 [TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease. Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399 [TBL] [Abstract][Full Text] [Related]
3. AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease. Passini MA; Macauley SL; Huff MR; Taksir TV; Bu J; Wu IH; Piepenhagen PA; Dodge JC; Shihabuddin LS; O'Riordan CR; Schuchman EH; Stewart GR Mol Ther; 2005 May; 11(5):754-62. PubMed ID: 15851014 [TBL] [Abstract][Full Text] [Related]
4. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration. Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708 [TBL] [Abstract][Full Text] [Related]
5. Injection of mouse and human neural stem cells into neonatal Niemann-Pick A model mice. Sidman RL; Li J; Stewart GR; Clarke J; Yang W; Snyder EY; Shihabuddin LS Brain Res; 2007 Apr; 1140():195-204. PubMed ID: 17289003 [TBL] [Abstract][Full Text] [Related]
6. Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology. Miranda SR; He X; Simonaro CM; Gatt S; Dagan A; Desnick RJ; Schuchman EH FASEB J; 2000 Oct; 14(13):1988-95. PubMed ID: 11023983 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease. Miranda SR; Erlich S; Friedrich VL; Gatt S; Schuchman EH Gene Ther; 2000 Oct; 7(20):1768-76. PubMed ID: 11083499 [TBL] [Abstract][Full Text] [Related]
8. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology. Shihabuddin LS; Numan S; Huff MR; Dodge JC; Clarke J; Macauley SL; Yang W; Taksir TV; Parsons G; Passini MA; Gage FH; Stewart GR J Neurosci; 2004 Nov; 24(47):10642-51. PubMed ID: 15564580 [TBL] [Abstract][Full Text] [Related]
9. AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease. Barbon CM; Ziegler RJ; Li C; Armentano D; Cherry M; Desnick RJ; Schuchman EH; Cheng SH Mol Ther; 2005 Sep; 12(3):431-40. PubMed ID: 16099409 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice. Dhami R; Passini MA; Schuchman EH Mol Ther; 2006 Mar; 13(3):556-64. PubMed ID: 16214420 [TBL] [Abstract][Full Text] [Related]
11. Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics. Murray JM; Thompson AM; Vitsky A; Hawes M; Chuang WL; Pacheco J; Wilson S; McPherson JM; Thurberg BL; Karey KP; Andrews L Mol Genet Metab; 2015 Feb; 114(2):217-25. PubMed ID: 25092414 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease. Ziegler RJ; Brown C; Barbon CM; D'Angona AM; Schuchman EH; Andrews L; Thurberg BL; McPherson JM; Karey KP; Cheng SH Mol Genet Metab; 2009 May; 97(1):35-42. PubMed ID: 19231265 [TBL] [Abstract][Full Text] [Related]
13. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease. Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517 [TBL] [Abstract][Full Text] [Related]